Marie Luise Hütter‐Krönke

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Jaume Capdevila, Lori J. Wirth, Thomas Ernst et al. · Journal of Clinical Oncology · 2020 · 335 citations · Full text

Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study

Albiruni R. Abdul Razak, Sebastian Bauer, Cristina Suárez et al. · Clinical Cancer Research · 2021 · 61 citations · Full text

Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors

Todd M. Bauer, Armando Santoro, Chia‐Chi Lin et al. · Journal for ImmunoTherapy of Cancer · 2023 · 33 citations · Full text

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

David J. Kuter, Waleed Ghanima, Nichola Cooper et al. · Blood · 2025 · 27 citations · Full text

Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

Marie Luise Hütter‐Krönke, Axel Benner, Konstanze Döhner et al. · Haematologica · 2016 · 21 citations · Full text